Uterus Transplantation From a Multi-organ Donor
1 other identifier
interventional
20
1 country
1
Brief Summary
Uterus transplantation: screening, in vitro fertilization \[IVF\] treatment to be able to freeze embryos, uterus transplantation, pregnancy and afterwards removal of the uterus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 3, 2016
CompletedFirst Submitted
Initial submission to the registry
June 22, 2017
CompletedFirst Posted
Study publicly available on registry
August 17, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
February 14, 2024
February 1, 2024
11.2 years
June 22, 2017
February 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Survival of the uterus 1 year after transplantation
Survival of the uterus 1 year after transplantation
1 year after uterus transplantation
Complications after uterus transplantation
Complications after uterus transplantation
As long as the uterus remains in situ (the uterus will be removed within one year after delivery)
Ongoing pregnancy rate
Ongoing pregnancy rate
4 weeks after embryo transfer
Take home baby rate
Take home baby rate
9 months after embryo transfer
Study Arms (1)
Uterus transplantation
EXPERIMENTALInterventions
transplantation of a uterus from a deceased donor
Eligibility Criteria
You may qualify if:
- Female with Maier-Rokitansky-Kuster-Hauser syndrome
- Mucosal neovagina of at least 7 cm
- In a stable relationship for at least 1 year
- Child wish
- Good renal function (and presence of both kidneys)
- Psychologically stable and compliant
- At least 8 frozen embryos after IVF/intracytoplasmic sperm injection \[ICSI\]
- Living in Belgium and a good health insurance
- Willing and able to provide informed consent
You may not qualify if:
- Major pelvic surgery
- Major chronic illnesses
- Other risk factors or malignancies
- BMI \> 30
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ghent University Hospital - Women's Clinic
Ghent, 9000, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 22, 2017
First Posted
August 17, 2017
Study Start
November 3, 2016
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
February 14, 2024
Record last verified: 2024-02